Advokatfirman Lindahl acts as an adviser in Abboxia’s merger with FrostPharma
Advokatfirman Lindahl represented the sellers of Abboxia in the strategic merger with FrostPharma. The two companies are now merging under the name of FrostPharma and will thus become one of the leading specialist pharmaceutical companies with the widest range of hospital drugs in the Nordic Region.
The merger combines FrostPharma’s commercial strength and strategic alliances with Abboxia’s development capacity, thus allowing more extensive supply of hospital medicines to Nordic healthcare providers.
The Lindahl team consisted of Svante Liljedahl, Olivia Sandin and Jannica Stefansson.
About FrostPharma and Abboxia
FrostPharma, which was founded in 2016, focuses on strategic partnerships and commercialisation of specialist pharmaceuticals in the Nordic market. Abboxia, which was founded in 2017, has developed several specialist medicines for the hospital segment in the Nordic Region.
Read more in the FrostPharma press release here.
Carousel items
-
4/9/2025
Viktor Wihlstrand: From Intern to Partner
Is it possible to work as a soldier and elite football player while climbing the career ladder as a newly graduated lawyer? Meet Viktor Wihlstrand, who today is a proud partner at Lindahl.
-
News articles
4/7/2025
Axel Hedberg appointed new CIO at Lindahl
Advokatfirman Lindahl is advancing its development and digitalisation journey by merging IT and Knowledge Management. The newly formed department will be led by Axel Hedberg, who has been appointed as CIO.
-
Cases and transactions
4/7/2025
Lindahl advisors to Amplex in two acquisitions
Lindahl has acted as legal advisor to Amplex in connection with the acquisition of all shares in the German company Filtertechnik Jäger GmbH and the Danish company GMV A/S.
-
Knowledge
3/27/2025
Termination Due to Poor Work Performance – How to Act Correctly as an Employer
As an employer, it can be challenging to know how to handle an employee who is not performing as expected and when it is serious enough to justify termination. The so-called LAS reform of 2022, where the term "objective grounds" was replaced with...
-
Read more news and insights?